Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Otsuka Holdings Co.
AddedFeb 13, 2024
UpdatedJun 28, 2026
Otsuka Holdings Co.

Otsuka Holdings Co.

Public

Otsuka Holdings: A healthcare solutions provider specializing in pharmaceuticals, nutraceuticals, and consumer products.

HQ
Tokyo, Tokyo, JP
Founded
2008
Overview
Compare
Employees
Website

Founded in 1964, Otsuka Holdings Co. is a diversified healthcare solutions provider headquartered in Japan. The company’s core mission is to contribute to the health and well-being of people worldwide through innovative products and services. Otsuka operates in the fields of pharmaceuticals, nutraceuticals, and consumer products, focusing on areas such as the nervous system, oncology, cardiovascular system, respiratory system, and infectious diseases. Their product portfolio includes electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Notable affiliated individuals include Akihiko Otsuka, who played a significant role in the company's expansion. Otsuka Holdings has received substantial investments from various global entities, bolstering its research and development capabilities. Key achievements include pioneering treatments in mental health and oncology, as well as the development of popular consumer health products like Pocari Sweat. Overall, Otsuka Holdings has made a significant impact on global healthcare by advancing medical research and providing accessible health solutions.

Otsuka Holdings Co. - Similar Companies

Taisho Pharmaceutical Holdings Co. logo

Taisho Pharmaceutical Holdings Co.

Taiho Pharmaceutical Co. logo

Taiho Pharmaceutical Co.

taiho.co.jp

Novartis Pharma logo

Novartis Pharma

Astellas Pharma logo

Astellas Pharma

Shionogi & Co. logo

Shionogi & Co.

Zenyaku Kogyo Co. logo

Zenyaku Kogyo Co.

zenyaku.co.jp

Daiichi Sankyo logo

Daiichi Sankyo

daiichisankyo.com

Kaigen Pharma Co. logo

Kaigen Pharma Co.

Eisai Co. logo

Eisai Co.

Kirin Holdings logo

Kirin Holdings

Ajinomoto logo

Ajinomoto

Sumitomo Pharma Co. logo

Sumitomo Pharma Co.

Kyowa Kirin Co. logo

Kyowa Kirin Co.

kyowakirin.com

Fuji Pharma Co. logo

Fuji Pharma Co.

ONO Pharmaceutical logo

ONO Pharmaceutical

Otsuka Holdings Co. - Quick Facts

Who are Otsuka Holdings Co.'s competitors?

Companies similar to Otsuka Holdings Co. include Taisho Pharmaceutical Holdings Co., Taiho Pharmaceutical Co., Novartis Pharma and Astellas Pharma.

When was Otsuka Holdings Co. founded?

Otsuka Holdings Co. was founded in 2008.

Where is Otsuka Holdings Co.'s headquarters located?

Otsuka Holdings Co.'s headquarters is located in Tokyo, Tokyo, JP.

How many employees does Otsuka Holdings Co. have?

Otsuka Holdings Co. has 33,482 employees as of Feb 6, 2024.

Otsuka Holdings Co. - Classification

Industry
  • Retail
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations